Ductular reaction-associated neutrophils promote biliary epithelium proliferation in chronic liver disease.
Ductular reaction
biliary cells
chronic injury
elastase
neutrophil extracellular traps
neutrophils
organoids
Journal
Journal of hepatology
ISSN: 1600-0641
Titre abrégé: J Hepatol
Pays: Netherlands
ID NLM: 8503886
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
02
12
2022
revised:
22
05
2023
accepted:
30
05
2023
pmc-release:
01
10
2024
medline:
18
9
2023
pubmed:
23
6
2023
entrez:
22
6
2023
Statut:
ppublish
Résumé
Ductular reaction expansion is associated with poor prognosis in patients with advanced liver disease. However, the mechanisms promoting biliary cell proliferation are largely unknown. Here, we identify neutrophils as drivers of biliary cell proliferation and the defective wound-healing response. The intrahepatic localization of neutrophils was evaluated in patients with chronic liver disease. Neutrophil dynamics were analyzed by intravital microscopy and neutrophil-labeling assays in DDC-treated mice. Neutrophil depletion or inhibition of recruitment was achieved using a Ly6g antibody or a CXCR1/2 inhibitor, respectively. Mice deficient in PAD4 (peptidyl arginine deiminase 4) and ELANE/NE (neutrophil elastase) were used to investigate the mechanisms underlying ductular reaction expansion. In this study we describe a population of ductular reaction-associated neutrophils (DRANs), which are in direct contact with biliary epithelial cells in chronic liver diseases and whose numbers increased in parallel with disease progression. We show that DRANs are immobilized at the site of ductular reaction for a prolonged period of time. In addition, liver neutrophils display a unique phenotypic and transcriptomic profile, showing a decreased phagocytic capacity and increased oxidative burst. Depletion of neutrophils or inhibition of their recruitment reduces DRANs and the expansion of ductular reaction, while mitigating liver fibrosis and angiogenesis. Mechanistically, neutrophils deficient in PAD4 and ELANE abrogate neutrophil-induced biliary cell proliferation, thus indicating the role of neutrophil extracellular traps and elastase release in ductular reaction expansion. Overall, our study reveals the accumulation of DRANs as a hallmark of advanced liver disease and a potential therapeutic target to mitigate ductular reaction and the maladaptive wound-healing response. Our results indicate that neutrophils are highly plastic and can have an extended lifespan. Moreover, we identify a new role of neutrophils as triggers of expansion of the biliary epithelium. Overall, the results of this study indicate that ductular reaction-associated neutrophils (or DRANs) are new players in the maladaptive tissue-healing response in chronic liver injury and may be a potential target for therapeutic interventions to reduce ductular reaction expansion and promote tissue repair in advanced liver disease.
Sections du résumé
BACKGROUND & AIMS
Ductular reaction expansion is associated with poor prognosis in patients with advanced liver disease. However, the mechanisms promoting biliary cell proliferation are largely unknown. Here, we identify neutrophils as drivers of biliary cell proliferation and the defective wound-healing response.
METHODS
The intrahepatic localization of neutrophils was evaluated in patients with chronic liver disease. Neutrophil dynamics were analyzed by intravital microscopy and neutrophil-labeling assays in DDC-treated mice. Neutrophil depletion or inhibition of recruitment was achieved using a Ly6g antibody or a CXCR1/2 inhibitor, respectively. Mice deficient in PAD4 (peptidyl arginine deiminase 4) and ELANE/NE (neutrophil elastase) were used to investigate the mechanisms underlying ductular reaction expansion.
RESULTS
In this study we describe a population of ductular reaction-associated neutrophils (DRANs), which are in direct contact with biliary epithelial cells in chronic liver diseases and whose numbers increased in parallel with disease progression. We show that DRANs are immobilized at the site of ductular reaction for a prolonged period of time. In addition, liver neutrophils display a unique phenotypic and transcriptomic profile, showing a decreased phagocytic capacity and increased oxidative burst. Depletion of neutrophils or inhibition of their recruitment reduces DRANs and the expansion of ductular reaction, while mitigating liver fibrosis and angiogenesis. Mechanistically, neutrophils deficient in PAD4 and ELANE abrogate neutrophil-induced biliary cell proliferation, thus indicating the role of neutrophil extracellular traps and elastase release in ductular reaction expansion.
CONCLUSIONS
Overall, our study reveals the accumulation of DRANs as a hallmark of advanced liver disease and a potential therapeutic target to mitigate ductular reaction and the maladaptive wound-healing response.
IMPACT AND IMPLICATIONS
Our results indicate that neutrophils are highly plastic and can have an extended lifespan. Moreover, we identify a new role of neutrophils as triggers of expansion of the biliary epithelium. Overall, the results of this study indicate that ductular reaction-associated neutrophils (or DRANs) are new players in the maladaptive tissue-healing response in chronic liver injury and may be a potential target for therapeutic interventions to reduce ductular reaction expansion and promote tissue repair in advanced liver disease.
Identifiants
pubmed: 37348790
pii: S0168-8278(23)00423-3
doi: 10.1016/j.jhep.2023.05.045
pmc: PMC10585421
mid: NIHMS1922727
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1025-1036Subventions
Organisme : NIAAA NIH HHS
ID : U01 AA021908
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA026972
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Références
Nat Immunol. 2018 Feb;19(2):192-201
pubmed: 29335647
J Clin Invest. 2019 Jul 11;129(10):4091-4109
pubmed: 31295147
Nature. 2022 Dec;612(7938):141-147
pubmed: 36352227
Hepatology. 2015 Aug;62(2):600-14
pubmed: 25855125
Immunol Rev. 2003 Jun;193:101-10
pubmed: 12752675
Blood. 2019 May 16;133(20):2178-2185
pubmed: 30898862
Gastroenterology. 2014 May;146(5):1231-9.e1-6
pubmed: 24440674
Hepatology. 2022 Feb;75(2):353-368
pubmed: 34490644
J Hepatol. 2023 Jan;78(1):28-44
pubmed: 36063965
Gut. 2022 Jul;71(7):1399-1411
pubmed: 34548339
Methods Mol Biol. 2019;1981:249-257
pubmed: 31016659
Cell Mol Life Sci. 2021 Feb;78(4):1329-1354
pubmed: 33078209
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2415-20
pubmed: 18272492
J Pathol. 2019 May;248(1):66-76
pubmed: 30584802
Science. 2018 Sep 28;361(6409):
pubmed: 30262472
Gastroenterology. 2013 Jun;144(7):1426-37, 1437.e1-9
pubmed: 23474284
Cell Death Dis. 2018 Jun 4;9(6):665
pubmed: 29867198
Hepatology. 2019 May;69(5):2180-2195
pubmed: 30565271
Sci Transl Med. 2021 Jun 23;13(599):
pubmed: 34162753
Cell. 2013 May 23;153(5):1025-35
pubmed: 23706740
Gastroenterology. 2014 Feb;146(2):349-56
pubmed: 24315991
Science. 2017 Oct 6;358(6359):111-116
pubmed: 28983053
Hepatology. 2012 Jun;55(6):1931-41
pubmed: 22278680
Cell Tissue Res. 2018 Mar;371(3):531-539
pubmed: 29383445
Oncogene. 2006 Jun 26;25(27):3818-22
pubmed: 16799623
Nat Commun. 2022 Aug 30;13(1):5111
pubmed: 36042192
Oncoimmunology. 2021 Jan 20;10(1):1870811
pubmed: 33537175
J Leukoc Biol. 2020 Oct;108(4):1199-1213
pubmed: 32422690
J Exp Med. 2018 Nov 5;215(11):2778-2795
pubmed: 30282719
J Hepatol. 2016 May;64(5):1041-1048
pubmed: 26719020
Nat Rev Gastroenterol Hepatol. 2019 May;16(5):269-281
pubmed: 30850822
Gastroenterology. 2019 Jul;157(1):193-209.e9
pubmed: 30872106
Hepatology. 2017 Feb;65(2):631-646
pubmed: 27775820
Toxicol Pathol. 2012;40(2):157-65
pubmed: 22105645
Nat Commun. 2019 Mar 6;10(1):1076
pubmed: 30842418
Gut. 2021 Feb;70(2):342-356
pubmed: 33214166
Hepatology. 2018 Oct;68(4):1347-1360
pubmed: 29631332
Cell. 2020 Nov 25;183(5):1282-1297.e18
pubmed: 33098771
Nature. 2020 Jul;583(7814):133-138
pubmed: 32528174
J Immunol. 2008 Dec 1;181(11):8053-67
pubmed: 19017998
J Hepatol. 2018 Nov;69(5):1145-1154
pubmed: 30030149
J Hepatol. 2022 Nov;77(5):1299-1310
pubmed: 35803543
Annu Rev Pathol. 2014;9:181-218
pubmed: 24050624
Cell Mol Immunol. 2020 May;17(5):433-450
pubmed: 32238918
J Hepatol. 2018 Apr;68(4):733-743
pubmed: 29154963